Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Health Inequities in Persons with Obesity & Type 2 Diabetes Exacerbated During COVID-19 Pandemic
Any viral infection can be a stressor for patients with obesity and type 2 diabetes (T2D), a population at risk for reduced immunity, however, “COVID-19 was huge,” said Shagun Bindlish, MD, medical director of One Medical in Dublin, California, in a recent interview with Patient Care Online. Dr Bindlish, joined by Dr Peminda K. Cabandugama, director of Digital Obesity at the Cleveland Clinic, sat down with Patient Care® to discuss the impact of the COVID-19 pandemic on obesity-related T2D, including the effect of quarantine and social distancing measures on overall health and how inequities were exacerbated in certain patient populations. More of their conversation follows.
Recent Videos
